SantosHuman Inc., U Ottawa, and U Waterloo Partner to Research Canadian Soldier Performance Tool

This year, SantosHuman Inc. will engage in research with the University of Ottawa and the University of Waterloo to develop and validate a tool to predict and optimize performance and minimize injury risk to Canadian Armed Forces (CAF) soldiers based on personal, operational, equipment and environmental factors.

FDA permits marketing of IDx-DR for automated detection of diabetic retinopathy in primary care

IDx, a privately-held AI diagnostics company, announced today that the U.S. Food and Drug Administration (FDA) has granted the company’s De Novo request to market IDx-DR, an AI-based diagnostic system for the autonomous detection of diabetic retinopathy, a leading cause of blindness. IDx-DR is the first autonomous, AI-based diagnostic system authorized for commercialization by the FDA.

Pages

Subscribe to News & Announcements